SenGenix sengenix.com

SenGenix is developing point-of-care diagnostic tests (POCT) based on fluorescently responsive sensors (FRS) that will deliver fast, accurate, actionable patient data at a low cost. The Company will commercialize protein-engineering technologies developed at Duke University Medical Center to create a product platform that will be designed to perform a menu of tests at the point-of-care. The product roll-out strategy over the next five years includes a stand-alone Creatinine test, and a Basic Met...Show all

SenGenix is developing point-of-care diagnostic tests (POCT) based on fluorescently responsive sensors (FRS) that will deliver fast, accurate, actionable patient data at a low cost. The Company will commercialize protein-engineering technologies deve...Show all

Company (Alive / Active)

All investors data 1 Investors

• Undisclosed Investors